Viewing data from:

DANAZOL

ANDA

DANAZOL | A074582 | BARR LABORATORIES INC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$2.59

per ea

Lowest NADAC/Unit

$1.56

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00555063502DANAZOL 200 MG CAPSULE	$2.59	EA	Generic	—	2026-06-17
00555063509DANAZOL 200 MG CAPSULE	$2.59	EA	Generic	—	2026-06-17
00555063402DANAZOL 100 MG CAPSULE	$2.33	EA	Generic	—	2026-06-17
00555063302DANAZOL 50 MG CAPSULE	$1.56	EA	Generic	—	2026-04-22

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$226.97

Highest Price

$567.53

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00555-0634-02DANAZOL 100MG CAP	$340.61	FSS	AvKare, LLC	06/14/2028
00555-0635-02DANAZOL 200MG CAP	$567.53	FSS	AvKare, LLC	06/14/2028
00555-0635-09DANAZOL 200MG CAP	$386.21	FSS	AvKare, LLC	06/14/2028
00555-0633-02DANAZOL 50MG CAP	$226.97	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain1 active DMF7 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CIPLA LTDDANAZOL USP

DMF 56161984

NV ORGANONInactiveDANAZOL

DMF 47401982

HOVIONE SOCIEDADE QUIMICA LDAInactiveDANAZOL

DMF 62871986

FINE CHEMICALS CORPInactiveDANAZOL USP

DMF 63901986

SCHERING AGInactiveDANAZOL

DMF 75841988

PROQUINA SAInactiveDANAZOL

DMF 76041988

RECORDATI CORPInactiveDANAZOL

DMF 79711989

PRODUCTOS QUIMICOS NATURALES SA DE CVInactiveDANAZOL

DMF 240212010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 200MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Aug 9, 1996

No patent or exclusivity listings for this strength.

#002 — 100MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 29, 1998

#003 — 50MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 29, 1998